Articles Tagged With:
-
Ethical Responses if Clinician Is Asked to Help Law Enforcement
When emergency medicine clinicians are caring for a patient in the custody of law enforcement, multiple ethical issues must be considered.
-
Big Data in Healthcare: Privacy Is Major Ethical Concern
Healthcare privacy is a central ethical concern involving the use of big data in healthcare, with vast amounts of personal information widely accessible electronically.
-
Pediatric End-Of-Life Care: An ‘Additional Layer Of Complexity’
Ethicists can encourage clinicians to consider language used to communicate with parents and ask about the family’s values to ensure ethical pediatric end-of-life care.
-
ICU Strain Speeds Timing to Withdrawal of Life-sustaining Therapy
During busy periods in the ICU, decision-making regarding withdrawal of life-sustaining therapy is made more quickly, found a recent study. Researchers analyzed the effect of ICU capacity strain on 9,891 patients dying in the hospital.
-
ED-Initiated Palliative Care Yields Dramatic Cost Savings
ED-initiated palliative care consults have the potential to decrease costs and length of stay, found a recent study.
-
Surrogate Decision-makers Face Ethical Questions If Patient Has Dementia
Even when the prior wishes of a patient with dementia were known, the process of decision-making was often fraught with complexity, found a recent study.
-
Stroke Risk From Use of Cannabis, Tobacco, and Alcohol
No associations between cannabis use in young adulthood and strokes later in life were found in multivariable models. An almost doubled risk of ischemic stroke was observed in those with cannabis use > 50 times; this risk was attenuated when adjusted for tobacco usage. Smoking ≥ 20 cigarettes per day was clearly associated both with strokes before 45 years of age and with strokes throughout the follow-up.
-
Intravenous Nutrient Therapies — Worth the Cost?
Intravenous nutrient therapies are gaining in popularity to help patients maintain overall wellness, enhance weight loss, boost immune function, increase athletic performance, cure hangovers, and treat particular conditions. However, the increase in the use of these therapies in both healthy individuals and those with health conditions has not translated into increased published research studies investigating efficacy and safety.
-
High-dose Biotin Shows Promise for Arresting Progressive Multiple Sclerosis Disability
In this double-blind, placebo-controlled study, patients with primary or secondary progressive multiple sclerosis were randomized to receive 100 mg of pharmaceutical-grade biotin or placebo thrice daily for 12 months. The primary endpoint of an improvement in the Expanded Disability Status Scale or a decrease in timed 25-foot walk time was achieved in 12.6% of the biotin-treated patients compared to no one in the placebo group (P = 0.005).
-
Do Facebook Friends Count — for Health and Longevity?
An observational examination of California Facebook users suggested this population has a lower mortality rate than non-Facebook users; the lowest mortality risk is for Facebook users who combine a moderate degree of online social interaction with high offline social activity.